What This MannKind Director Signals Risk to Royalties
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
120 articles
What This Cytokinetics Insider Sale Signals Stock Surge
A Cytokinetics insider sale coincides with a stunning stock move. This article breaks down what the trade might signa...
Here's Vertex Willing Premium: Inside the Crinetics Deal
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Stock Skyrocketed Today: What Drove Q32 Bio Surge
When biotech headlines hit, stocks can swing quickly. Here’s a grounded look at why stock skyrocketed today for Q32 B...
Does Vertex's Acquisition Crinetics Make Stock a Buy?
If Vertex pursues Crinetics, what would it mean for the stock? This article breaks down potential value, risks, and t...
Kymera's Sold Million Stock: Insider Move or Signal Ahead
Kymera’s CEO recently monetized a sizable stake after a strong run. This article unpacks the insider sale, what kymer...
What This Apogee Insider Move After 247% Run Might Mean
A dramatic insider move at Apogee comes after a steep stock rise. This article breaks down the possible meanings, ris...
Taysha's Chief Sold $1.2: What It Means for Investors
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Related Topics
#Stock Analysis (30)
#Earnings Analysis (22)
#Portfolio Management (18)
#Insider Trading (16)
#Stock Market (14)
#Portfolio Strategy (14)
#Investing (11)
#risk-management (8)
#Hedge Funds (7)
#Stock Market Analysis (6)
#Earnings (5)
#Healthcare Stocks (5)
#SEC Filings (5)
#Investment Strategy (4)
#Stock Market News (4)